• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The role of chemotherapy in cholangiocarcinoma.

作者信息

Thongprasert S

机构信息

Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chiang Mai, University, Chiang Mai, Thailand.

出版信息

Ann Oncol. 2005;16 Suppl 2:ii93-6. doi: 10.1093/annonc/mdi712.

DOI:10.1093/annonc/mdi712
PMID:15958484
Abstract
摘要

相似文献

1
The role of chemotherapy in cholangiocarcinoma.化疗在胆管癌中的作用。
Ann Oncol. 2005;16 Suppl 2:ii93-6. doi: 10.1093/annonc/mdi712.
2
[Effectiveness of systemic chemotherapy of GEM+CBDCA+5-FU/LV and hepatic arterial infusion of CDDP in a case of advanced, combined hepatocellular-cholangiocarcinoma with multiple lung metastases].[吉西他滨+顺铂+5-氟尿嘧啶/亚叶酸钙全身化疗联合肝动脉灌注顺铂治疗晚期混合型肝细胞胆管癌伴多发肺转移1例的疗效]
Nihon Shokakibyo Gakkai Zasshi. 2011 Nov;108(11):1892-901.
3
Gemcitabine combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced carcinoma of the pancreas.吉西他滨联合持续输注5-氟尿嘧啶和大剂量亚叶酸钙治疗晚期胰腺癌。
Chemotherapy. 2004 Jun;50(3):127-32. doi: 10.1159/000077886.
4
Gemcitabine doublets in advanced pancreatic cancer: should we move on?晚期胰腺癌中的吉西他滨双联方案：我们是否应继续采用？
J Clin Oncol. 2006 Jan 20;24(3):327-9. doi: 10.1200/JCO.2005.03.8315. Epub 2005 Dec 12.
5
[Systemic chemotherapy with gemcitabine for advanced biliary tract carcinoma].吉西他滨全身化疗用于晚期胆管癌
Nihon Rinsho. 2006 Jan;64 Suppl 1:534-8.
6
On prejudice and facts and choices.关于偏见、事实与选择。
Ann Oncol. 2006 Feb;17(2):185-7. doi: 10.1093/annonc/mdj142.
7
Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.基于吉西他滨的晚期胆管癌化疗
Cochrane Database Syst Rev. 2018 Apr 6;4(4):CD011746. doi: 10.1002/14651858.CD011746.pub2.
8
Systemic gemcitabine combined with hepatic arterial infusion chemotherapy with cisplatin, 5-fluorouracil, and isovorin for the treatment of advanced intrahepatic cholangiocarcinoma: a pilot study.吉西他滨全身化疗联合顺铂、5-氟尿嘧啶及亚叶酸钙肝动脉灌注化疗治疗晚期肝内胆管癌的前瞻性研究
Hepatogastroenterology. 2014 Jan-Feb;61(129):162-7.
9
Effect of Adjuvant Gemcitabine Combined with Low-dose 5-Fluorouracil and Cisplatin Chemotherapy for Advanced Biliary Carcinoma.吉西他滨联合低剂量氟尿嘧啶和顺铂辅助化疗治疗晚期胆管癌的疗效
Anticancer Res. 2017 Nov;37(11):6421-6428. doi: 10.21873/anticanres.12096.
10
[A case of intrahepatic cholangiocarcinoma effectively treated by hepatic arterial infusion chemotherapy].[1例经肝动脉灌注化疗有效治疗的肝内胆管癌]
Gan To Kagaku Ryoho. 2006 Nov;33(11):1657-9.

引用本文的文献

1
Emerging HER2 Targeting Immunotherapy for Cholangiocarcinoma.新兴的针对胆管癌的HER2靶向免疫疗法。
Oncol Res. 2025 Aug 28;33(9):2279-2307. doi: 10.32604/or.2025.065319. eCollection 2025.
2
Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response.基于影像学测量的肝内胆管癌放疗后强化变化反映了反应的物理机制。
medRxiv. 2024 Sep 12:2024.09.11.24313334. doi: 10.1101/2024.09.11.24313334.
3
Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma.
蛋白质组学和生物信息学鉴定胆管癌中具有预后潜力的耐药相关基因。
Biomolecules. 2024 Aug 8;14(8):969. doi: 10.3390/biom14080969.
4
MiR-200b-3p elevates 5-FU sensitivity in cholangiocarcinoma cells via autophagy inhibition by targeting KLF4.微小RNA-200b-3p通过靶向KLF4抑制自噬来提高胆管癌细胞对5-氟尿嘧啶的敏感性。
Noncoding RNA Res. 2024 Jun 7;9(4):1098-1110. doi: 10.1016/j.ncrna.2024.06.004. eCollection 2024 Dec.
5
Circulating Immune Cells Predict Prognosis and Clinical Response to Chemotherapy in Cholangiocarcinoma.循环免疫细胞可预测胆管癌的预后及对化疗的临床反应。
Curr Med Chem. 2025;32(3):595-607. doi: 10.2174/0109298673296618240424095548.
6
Immunomodulation exerted by galectins: a land of opportunity in rare cancers.半乳糖凝集素发挥的免疫调节作用：稀有癌症的机遇之地。
Front Immunol. 2023 Nov 8;14:1301025. doi: 10.3389/fimmu.2023.1301025. eCollection 2023.
7
Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma.白细胞介素-6衍生的癌症相关成纤维细胞激活STAT3信号通路，导致胆管癌对吉西他滨耐药。
Front Pharmacol. 2022 Aug 26;13:897368. doi: 10.3389/fphar.2022.897368. eCollection 2022.
8
Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma.美国食品药品监督管理局批准的胆管癌靶向治疗时间表。
Cancers (Basel). 2022 May 26;14(11):2641. doi: 10.3390/cancers14112641.
9
Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States.不可切除肝内胆管癌的消融性肝放疗：美国的治疗模式和生存情况。
Cancer. 2022 Jul 1;128(13):2529-2539. doi: 10.1002/cncr.34223. Epub 2022 Apr 13.
10
Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma.分子特征性肝内胆管癌消融放疗后的疗效基准评估
J Pers Med. 2021 Dec 1;11(12):1270. doi: 10.3390/jpm11121270.